FDA
2017 was the second-best year for FDA approvals since 1996.
The FDA approved Merck’s and Pfizer’s Steglatro, a SGLT2-inhibitor, that will square off against established drugs in the market.
The FDA broke new ground today with a first-of-its-kind therapy for eye disease.
Christmas came a week early for Aerie Pharmaceuticals.
The approval of HAnano Surface in the United States has been executed in accordance with the new 510(k) legislation for medical devices.
A look at the latest batch of FDA approvals this year.
This could be the first step in a long journey that could amount to huge profitability for the iPhone maker.
Foundation Medicine’s sequencing diagnostics test for solid tumors that can detect cancer-causing mutations in 324 genes was approved by the FDA Thursday.
HIV patients have a new maintenance drug in their arsenal of medication.
A look at the 19 spine-related medical devices the FDA cleared in October.
PRESS RELEASES